[{"address1": "14/15 Conduit Street", "city": "London", "zip": "W1S 2XJ", "country": "United Kingdom", "phone": "44 20 7495 2379", "website": "https://www.tizianalifesciences.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Tiziana Life Sciences Ltd, a biotechnology company, specializes in the development of transformative therapies for neurodegenerative and lung diseases in the United States. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It also develops TZLS-501, a fully human mAb targeting the IL-6 receptor for the treatment of inflammatory and oncology indications. Tiziana Life Sciences Ltd was incorporated in 1998 and is headquartered in London, the United Kingdom.", "fullTimeEmployees": 9, "companyOfficers": [{"maxAge": 1, "name": "Mr. Gabriele Marco Antonio Cerrone M.B.A.", "age": 52, "title": "Founder & Executive Chairman", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 1853000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ivor R. Elrifi Ph.D.", "title": "CEO & Executive Director", "fiscalYear": 2024, "totalPay": 131000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Keeren  Shah", "age": 48, "title": "COO & CFO", "yearBorn": 1976, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. William A. Clementi Ph.D., Pharm.D.", "title": "Chief Development Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Napoleone  Ferrara M.D.", "age": 67, "title": "Member of Scientific Advisory Board", "yearBorn": 1957, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.39, "open": 1.39, "dayLow": 1.35, "dayHigh": 1.4999, "regularMarketPreviousClose": 1.39, "regularMarketOpen": 1.39, "regularMarketDayLow": 1.35, "regularMarketDayHigh": 1.4999, "payoutRatio": 0.0, "beta": 0.126, "forwardPE": -27.2, "volume": 156380, "regularMarketVolume": 156380, "averageVolume": 747166, "averageVolume10days": 647620, "averageDailyVolume10Day": 647620, "bid": 1.34, "ask": 1.4, "bidSize": 8, "askSize": 1, "marketCap": 158913280, "fiftyTwoWeekLow": 0.63, "fiftyTwoWeekHigh": 1.91, "fiftyDayAverage": 1.2436, "twoHundredDayAverage": 1.0175, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 147971152, "profitMargins": 0.0, "floatShares": 72114084, "sharesOutstanding": 116848000, "sharesShort": 957043, "sharesShortPriorMonth": 752459, "sharesShortPreviousMonthDate": 1743379200, "dateShortInterest": 1745971200, "sharesPercentSharesOut": 0.0082, "heldPercentInsiders": 0.35301998, "heldPercentInstitutions": 0.027290002, "shortRatio": 2.91, "shortPercentOfFloat": 0.0123000005, "impliedSharesOutstanding": 116848000, "bookValue": 0.035, "priceToBook": 38.857143, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -11863000, "trailingEps": -0.11, "forwardEps": -0.05, "lastSplitFactor": "2499:1000", "lastSplitDate": 1596153600, "enterpriseToEbitda": -9.376, "52WeekChange": 0.7662338, "SandP52WeekChange": 0.12250078, "quoteType": "EQUITY", "currentPrice": 1.36, "recommendationKey": "none", "totalCash": 3724000, "totalCashPerShare": 0.033, "ebitda": -15782000, "totalDebt": 106000, "quickRatio": 1.002, "currentRatio": 1.022, "debtToEquity": 2.693, "returnOnAssets": -0.84125, "returnOnEquity": -2.50486, "freeCashflow": -588250, "operatingCashflow": -1526000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "TLSA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "regularMarketChangePercent": -2.1582713, "regularMarketPrice": 1.36, "shortName": "Tiziana Life Sciences Ltd", "longName": "Tiziana Life Sciences Ltd", "corporateActions": [], "postMarketTime": 1747432820, "regularMarketTime": 1747425600, "exchange": "NCM", "messageBoardId": "finmb_261234197", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1542724200000, "postMarketChangePercent": -0.735293, "postMarketPrice": 1.35, "postMarketChange": -0.00999999, "regularMarketChange": -0.029999971, "regularMarketDayRange": "1.35 - 1.4999", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 747166, "fiftyTwoWeekLowChange": 0.73, "fiftyTwoWeekLowChangePercent": 1.1587301, "fiftyTwoWeekRange": "0.63 - 1.91", "fiftyTwoWeekHighChange": -0.54999995, "fiftyTwoWeekHighChangePercent": -0.2879581, "fiftyTwoWeekChangePercent": 76.62338, "earningsTimestampStart": 1747684800, "earningsTimestampEnd": 1748030400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.11, "epsForward": -0.05, "fiftyDayAverageChange": 0.1164, "fiftyDayAverageChangePercent": 0.09359923, "twoHundredDayAverageChange": 0.34249997, "twoHundredDayAverageChangePercent": 0.3366093, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Tiziana Life Sciences PLC", "nameChangeDate": "2025-05-14", "cryptoTradeable": false, "displayName": "Tiziana Life Sciences", "trailingPegRatio": null, "__fetch_time": "2025-05-17"}]